Nitric Oxide Levels in Peripheral Blood as an Indicator of Microvascular Anastomotic Patency

ABSTRACT

Nitric oxide (NO) was first recognized as the endothelial-derived relaxing factor in 1987, and since then has been extensively studied. It was found to be involved in almost every physiologic or pathophysiologic process in human biology. This study examined the correlation between peripheral blood levels of NO and the microvascular anastomotic patency of an infrarenal aortic anastomosis in a rat model. Four groups of six Sprague-Dawley rats each were studied. Three groups underwent microsurgical manipulation which included: anastomosis followed by ligation of the aorta in one group; anastomosis of the aorta in another; and dissection of the infrarenal aorta in the third group. A fourth group served as controls. Peripheral blood samples for NO levels were taken at different times before and during the first 24 hr after surgery.

Results demonstrated a transient rise of NO levels in all operated groups. The ligated group exhibited the most prominent rise in NO blood levels. This rise was statistically significant, compared to the rise in other groups during the first 6 hr postoperatively. The anastomosed group levels were only mildly higher than the dissected group, showing no statistically significant difference postoperatively. NO blood levels in all of the groups returned to baseline at 24 hr postoperatively. The study shows that changes in NO levels in peripheral blood are detectable after microsurgical manipulation of the infrarenal aorta in a rat model. Furthermore, in rats undergoing ligation of the anastomosed aorta, mimicking anastomotic occlusion, NO peripheral blood levels are significantly higher than when the anastomosis remains patent.

KEYWORDS

Nitric oxide - microsurgery - vascular anastomosis - rat model

REFERENCES

• 1 Palmer R MJ, Ferrige A G, Moncada S. Release of nitric oxide accounts for the biological activity of endothelium-derived relaxing factor.  Nature . 1987;  327 524-526
• 2 Garthwaite J, Charles S L, Chess-Williams R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.  Nature . 1988;  336 385-388
• 3 Rand M J. Nitrergic transmission: nitric oxide as mediator of non-adrenergic, non-cholinergic neuro-effector transmission.  Clin Exp Pharmacol Physiol . 1992;  19 147-169
• 4 Morris Jr M S, Billiar T R. New insights into the regulation of inducible nitric oxide synthesis.  Am J Physiol . 1994;  266 E829-839
• 5 Sessa W C. The nitric oxide synthase family of proteins.  J Vasc Res . 1994;  31 131-143
• 6 Billiar T R. Nitric oxide: novel biology with clinical relevance.  Ann Surg . 1995;  221 339-349
• 7 Lipton S A, Choi Y-B, Pan Z-H. A redox-based mechanism for the neuroprotective and neurodestructive effect of nitric oxide and related nitroso-compounds.  Nature . 1993;  364 626-631
• 8 Davies M G, Fulton G J, Hagen P O. Clinical biology of nitric oxide.  Br J Surg . 1995;  82 1598-1610
• 9 Hansson G K, Geng Y G, Holm J. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury.  J Exp Med . 1994;  180 733-738
• 10 Green D P. Operative hand surgery, 2^nd ed. Edinburgh, London: Churchill Livingstone 1998
• 11 Engelman D T, Watanabe M, Engelman R M. Constitutive nitric oxide release is impaired after ischemia and reperfusion.  J Thorac Cardiovasc Surg . 1995;  110(4 Pt 1) 1047-1053
• 12 Cuzzocrea S, Zingarelli B, Caputi A P. Role of constitutive nitric oxide synthase and peroxynitrite production in a rat model of splanchnic artery occlusion shock.  Life Sci . 1998;  63 789-799
• 13 Summers S T, Zinner M J, Freischlag J A. Production of EDRF is compromised after ischemia and reperfusion.  Am J Surg . 1993;  166 216-220
• 14 Tsao P S, Aoki N, Lefer D J. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat.  Circulation . 1990;  82 1402-1412
• 15 Gribbe O, Lundeberg T, Samuelson U E, Wiklund N P. Dexamethasone increases survival and attenuates induction of inducible nitric oxide synthase in experimental skin flaps.  Ann Plast Surg . 1999;  42 180-184
• 16 Phan L H, Hickey M J, Niazi Z B, Stewart A G. Nitric oxide synthase inhibitor, nitro-iminoethyl-L-ornithine, reduces ischemia reperfusion injury in rabbit skeletal muscle.  Microsurgery . 1994;  15 703-707
• 17 Knight K R, Zhang B, Morrison W A, Stewart A G. Ischemia reperfusion injury in mouse skeletal muscle is reduced by N omega-nitro-L-arginine methyl ester and dexamethasone.  Eur J Pharmacol . 1997;  332 273-278
• 18 Gribbe O, Lundeberg T, Samuelson U E, Wiklund N P. Nitric oxide synthase activity and endothelial ultrastructure in ischemic skin flaps.  Br J Plast Surg . 1997;  50 483-490
• 19 Oshima H. The influence of skin flap ischemia on serum nitric oxide concentrations.  Microsurgery . 1996;  17 191-197
• 20 Wei F C, Chang Y C, Lee Y H. Comparison of skeletal muscle microcirculation between clamp ischemia and microsurgical ischemia.  Microsurgery . 1996;  17 123-127
• 21 Qi W E, Chen L E, Seaber A V, Urbaniak J R. Regulation of NOS mRNA expression in reperfused muscle.  Microsurgery . 1999;  19 18-19
• 22 Margic K. Early changes in dissected small vessels: experimental study on rat arteries and veins.  Plast Reconstr Surg . 1985;  75 375-383
• 23 Tzeng E, Billiar T R. Nitric oxide and the surgical patient.  Arch Surg . 1997;  132 977-982
• 24 Petrasek P F, Homer-Vanniasinkam S, Walker P M. Determinants of ischemic injury to skeletal muscle.  J Vasc Surg . 1994;  19 623-631
• 25 Kelts K A, Kaiser K K. Experimental ischemic myopathy. Effects of aortic ligation and serotonin.  J Neurol Sci . 1979;  40 23-27
• 26 Griscavage J M, Rogers N E, Sherman M P, Ignarro L J. Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide.  J Immunol . 1993;  151 6329-6337
• 27 Buga G M, Griscavage J M, Rogers N E, Ignarro L J. Negative feedback regulation of endothelial cell function by nitric oxide.  Circ Res . 1993;  73 808-812